ECIAOTCSurgical & Medical Instruments & ApparatusFiscal year ends March 31
ENCISION INC
Financials through Q2 FY2026, quarter ended Sep 30, 2025Last filing: 10-Q on Nov 13, 2025
$0.01+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $163.15K
- P/E (TTM)
- –
- Dividend yield
- –
ENCISION INC revenue by segment
By business segment
By product or service
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product [Member] | $5.95M | $6.12M | $6.22M | $6.21M | $6.31M | $6.41M | $6.43M | $6.73M | $6.85M | $6.80M | $6.89M | $6.65M | 94.4% | -5.8% |
| Service [Member] | $353.23K | $408.55K | $337.63K | $288.36K | $180.64K | $153.05K | $153.91K | $138.99K | $118.53K | $44.55K | $463.36K | $493.99K | 5.6% | +95.5% |
By region
From the segment and revenue-disaggregation notes of Encision's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.